Advanced search
Publication Cover
Journal of Nutritional & Environmental Medicine Volume 9, 1999 - Issue 1
Journal homepage
2
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Is ISIS-4 research misconduct?

DAMIEN DOWNING BSAENM, PO Box 3AP, London W1A 3AP, UK
Pages 5-13 | Published online: 13 Jul 2009

  • Malkiel-Shapiro B. Further observations on parenteral magnesium sulfate therapy in coronary heart disease: a clinical appraisal. S Afr Med J 1958; 32: 1211.
  • Parsons RS, et al. The treatment of coronary artery disease with parenteral magnesium sulfate. Med Proc 1959; 5: 487-98.
  • Seelig M.S. Magnesium deficiency in the pathogenesis of disease. In: Plenum Medical Book, New York and London 1980.
  • Morgan K.J., Stampley G.L., Zabik M.E., Fischer D.R.: Magnesium and Calcium Dietary Intakes of the U.S. Population. J Am Coll Nutr 1985; 4: 195-206.
  • Morton BC, Smith FM, Nair RC, McKibbon TG, Poznanski WJ. Magnesium therapy in acute myocardial infarction: a double blind study. Magnesium 1984; 3: 346-52.
  • Rasmussen HS, McNair P, Norregard P, Backer V, Lindeneg O, Balslev S. Intravenous magnesium in acute myocardial infarction. Lancet 1986; l: 234-6.
  • Rasmussen HS, Gronbaek M, Cintin C, Balslev S, Norregard P, McNair P. One-year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo. Clin Cardiol 1988; 11: 377-81.
  • Smith LF, Heagerty AM, Bing RF, Barnett DB. Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality. Int J Cardiol 1986; 12: 175-80.
  • Shechter M, Hod H, Marks N, Kaplinsky E, Behar S, Rabinowitz B. Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol 1990; 66: 271-4.
  • Bertschat F, Ising H, Gilnther T, et al. Antiarrhythmic effects of magnesium infusions in patients with acute myocardial infarction. Magnesium Bull 1989; ii: 155-8.
  • Singh RB, Sircar AR, Rastogi SS, Garg V, Magnesium and potassium administration in acute myocardial infarction Magnes Trace Elem 1990; 9: 198-204.
  • Ceremuzynski L, Jurgiel R, KulakowskiP, Gebalska J. Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulphate. Am Heart J 1989; 118: 1333-4.
  • Abraham AS, Rosenmann D, Kramer M, et al. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Arch Intern Med 1987; 147:753-5
  • Feldstedt M, Boesgaard S et al. Magnesium substitution in acute ischaemic heart syndromes. Eur Heart J 1991; 12: 1215-8.
  • Lau J., Elliott M., Antman M.D., Jimenez-Silva J., Kupelnick B., Mosteller F., Chalmers T.C., Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction. N Engl J Med 1992; 327(4): 248-54.
  • Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ 1991; 303:1499-503.
  • Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium intervention Trial (LIMIT-2). Lancet 1992; 339: 1553-58.
  • Woods K.L., Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium intervention Trial (LIMIT-2). Lancet 1995; 343: 816-9.
  • ISIS-4 Collaborative Group. Fourth International Study of Infarct Survival: Protocol for a Large Simple Study of the Effects of Oral Mononitrate, of Oral Captopril, and of Intravenous Magnesium. Am J Cardiol 1991; 86: 87D-100D.
  • ISIS-4 Collaborative Group. ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-85.
  • Yusuf S, Flather M. Magnesium in acute myocardial infarction (Editorial). BMJ 1995; 310: 751-2.
  • Egger M, Davey Smith G. Misleading meta-analysis (Editorial). BMJ 1995; 310: 752-4.
  • Woods KL. Mega-trials and management of acute myocardial infarction. Lancet 1995; 346:611-14.
  • Seelig MS, Elin RJ. Is there a place for magnesium in the treatment of acute myocardial infarction? Am Ht J 1996; 132:471-76.
  • Conway M, Mohideen R et al. A dose-finding study for the initiation of captopril within 24 h of acute myocardial infarction. (Pre-pilot study for ISIS-4). Q J Med. 1989; 70-73: 973- 4.
  • Pipilis A, Flather M, Collins R, Conway M, Sleight P. ISIS-4 pilot study: serial haemodynamic changes with oral captopril and oral isosorbide mononitrate in a randomised double-blind trial in acute myocardial infarction. J Am Coll. Cardiol 1991; 17:115A.
  • Rayssiguier Y. Magnesium and Lipids Interrelationships in the Pathogenesis of Vascular Diseases. Magnesium-Bulletin 1981; 3:165-77.
  • Durlach J. Pilule et Thrombose; ou des Plaquettes, des Estrogenes et du Magnesium. Revue Francais Endocrinologie Clinique 1970; 11: 45-54.
  • Haddy FJ, Seelig MS. Magnesium and the Arteries. Il. Physiologic Effects of Electrolyte Abnormalities in Arterial Resistance. In: Magnesium in Health and Disease. Eds. M. Cantin & M.S. Seelig. Publ. SP Medical & Scientific Books, New York. 1980; 639-57.
  • Flink EB, Brick JE, Shane SR. Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction Arch Intern Med 1981;141:441-3.
  • Reimer KA, Lowe JE, Rasmussen MM, et al. The wave-front phenomenon of ischaemic cell death 1: Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977; 56: 786-94.
  • Reimer KA, Jennings RB. The 'wavefront phenomenon' of myocardial ischaemic cell death II. Transmural progression of necrosis within the framework of ischaemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979; 40: 633-44.
  • Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest 1985; 76: 1713-19.
  • Chang C, Varghese PJ, Downey J, Bloom S. Magnesium deficiency and myocardial infarct size in the dog. J Am Coll Cardiol 1985; 5: 2622-26.
  • Barros LFM, Chagas ACP, da Luz PL, Pileggi F. Magnesium treatment of acute myocardial infarction: effects on necrosis in an occlusion/reperfusion dog model. Int J Cardiol 1995; 48: 3-9.
  • Christiansen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarction size when administered before but not after coronary reperfusion in a canine model. Circulation 1995; 92: 2617-21.
  • Herzog WR, Schlossberg ML, MacMurdy KS, et al. Timing of magnesium therapy affects experimental infarct size. Circulation 1995; 92: 2622-26.
  • Leor J, Kloner RA. An experimental model examining the role of magnesium in the therapy of acute myocardial infarction. Am J Cardiol 1995; 75: 1292-93.
  • Thogersen AM, Johnson O, Wester PO. Effects of intravenous magnesium sulphate in suspected acute myocardial infarction on acute arrhythmias and long-term outcome. Int J Cardiol 1995; 49: 143-51.
  • Barghava B, Chandra S, Agarwal VV, Kaul U, Vashishth S, Wasir HS. Adjunctive magnesium infusion therapy in acute myocardial infarction. Int J Cardiol 1993; 39: 13-22.
  • Schecter M, Hod H. Magnesium therapy in aged patients with acute myocardial infarction. Mag Bull 1991; 13: 7-9.
  • Antman EM. Magnesium in acute myocardial infarction: Overview of available evidence. Am Ht J 1996; 132: 487-95.
  • Fisher J, Abrams J. Life-threatening ventricular tachyarrhythmias in delirium tremens. Arch Intern Med 1977; 137: 1238-43.
  • Levine SR, Crowley TJ, Hai HA. hypomagnesemia and ventricular tachycardia: a complication of ulcerative colitis and parenteral hyperalimentation in non-digitalised, non-cardiac patients. Chest 1982; 81: 244-47.
  • Antman EM, Lau J, Berkey C, McIntosh M, Chalmers TC, Mosteller F. Large versus small trials of magnesium for acute myocardial infarction: big numbers do not tell the whole story. Circulation 1994; 90(supp I):325.
  • Shechter M, Hod H, Kaplinsky E, Chouraqui P, Rabinowitz B. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol 1995; 75: 321-3.
  • Seelig MS, Elin RJ. Reexamination of magnesium infusions in myocardial infarction. Am J Cardiol 1995; 76: 172-3.
  • Baxter GF, Sumeray MS, Walker JM. Infarct size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet 1996; 348: 1424-26.
  • Downing D. The Avoidance of Tabloid Science (Editorial). J Nutr Med 1991; 2: 347-50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.